Modulating the Microbiome for Crohn's Disease Treatment

Area of Science:

• Microbiology and Immunology
• Gastroenterology
• Pharmacology

Background:

• The gut microbiota, comprising bacterial (bacteriome) and fungal (mycobiome) communities, plays a crucial role in host health and disease.
• Polymicrobial interactions within the gut ecosystem, alongside host-microbiota bidirectional communication, significantly impact health outcomes.
• Gut microbiota can influence host immune responses and drug efficacy by altering drug bioavailability, activity, and toxicity, particularly when biofilms are present.

Approach:

• This review explores the complex bidirectional interactions between the host and gut microbes.
• It examines how probiotic and prebiotic interventions modulate gut microbiota composition and function.
• A systematic approach for designing targeted probiotics to alter microbiota in disease states, using Crohn's disease as a model, is outlined.

Key Points:

• Gut microbiota composition is influenced by host immunity, therapeutics, and environmental factors.
• Biofilm formation by gut microbes can lead to increased gut permeability, antimicrobial resistance, and altered immune responses.
• Probiotics and prebiotics represent natural strategies for modulating the gut microbiome.

Conclusions:

• Understanding the impact of gut microbiota on treatment efficacy is key to developing novel therapeutic strategies.
• Modulating the gut microbiome through natural approaches like probiotics and prebiotics holds potential for improving treatment outcomes in various diseases.
• Targeted microbiome modulation could enhance therapeutic effectiveness, particularly in chronic conditions like Crohn's disease.